These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 3448133)

  • 21. Illegal importation of pharmaceuticals: implications for community pharmacy and public health.
    Fuller C
    Manag Care; 2004 Mar; 13(3 Suppl):34-5. PubMed ID: 15074169
    [No Abstract]   [Full Text] [Related]  

  • 22. Friction and fact in the marketing of pharmaceuticals and biologics.
    Herrick JB
    J Am Vet Med Assoc; 1992 Aug; 201(4):556-7. PubMed ID: 1517128
    [No Abstract]   [Full Text] [Related]  

  • 23. Drug studies in developing countries.
    Olliaro PL; Vijayan R; Inbasegaran K; Lang CC; Looareesuwan S
    Bull World Health Organ; 2001; 79(9):894-5. PubMed ID: 11584742
    [No Abstract]   [Full Text] [Related]  

  • 24. Using drug samples can hinder quality.
    Healthcare Benchmarks Qual Improv; 2004 Mar; 11(3):34-5. PubMed ID: 15002360
    [TBL] [Abstract][Full Text] [Related]  

  • 25. TRIPS, pharmaceutical patents, and access to essential medicines: a long way from Seattle to Doha.
    't Hoen E
    Chic J Int Law; 2002; 3(1):27-46. PubMed ID: 15709298
    [No Abstract]   [Full Text] [Related]  

  • 26. Creating reliable pharmaceutical distribution networks and supply chains in African countries: Implications for access to medicines.
    Tetteh E
    Res Social Adm Pharm; 2009 Sep; 5(3):286-97. PubMed ID: 19733829
    [No Abstract]   [Full Text] [Related]  

  • 27. Drug patent plan gets mixed reviews.
    Butler D
    Nature; 2009 Feb; 457(7233):1064. PubMed ID: 19256077
    [No Abstract]   [Full Text] [Related]  

  • 28. Biotech products pose distribution challenges.
    Szeinbach SL; Gillenwater EL
    Am Pharm; 1994 Mar; NS34(3):19-20. PubMed ID: 8192094
    [No Abstract]   [Full Text] [Related]  

  • 29. [Is openness in the drug market possible?].
    Dölle W; Schwabe U
    Internist (Berl); 1986 Jan; 27(1):21-31. PubMed ID: 3514513
    [No Abstract]   [Full Text] [Related]  

  • 30. Drug distribution dynamo. Cardinal Health, Bergen Brunswig propose mega-merger.
    Hensley S
    Mod Healthc; 1997 Sep; 27(35):20. PubMed ID: 10173141
    [No Abstract]   [Full Text] [Related]  

  • 31. Are rich nations up for drug reform?
    Check E
    Nature; 2006 May; 441(7090):135. PubMed ID: 16688137
    [No Abstract]   [Full Text] [Related]  

  • 32. Health care for all by 2000 A.D.--can India achieve the objective?
    Kumaraswami TM
    J Indian Med Assoc; 1984 Nov; 82(11):418-20. PubMed ID: 6535807
    [No Abstract]   [Full Text] [Related]  

  • 33. Impact of gatt agreement on drug prices.
    Pillai AM
    J Indian Med Assoc; 1995 Mar; 93(3):113, 120. PubMed ID: 8522810
    [No Abstract]   [Full Text] [Related]  

  • 34. ASHP guidelines for selecting pharmaceutical manufacturers and suppliers.
    Am J Hosp Pharm; 1991 Mar; 48(3):523-4. PubMed ID: 2029002
    [No Abstract]   [Full Text] [Related]  

  • 35. Rationale drug therapy: reasons for failure and suggestions for its implementation.
    Mathur GP; Kushwaha KP; Mathur S
    Indian Pediatr; 1993 Jun; 30(6):815-8. PubMed ID: 7726879
    [No Abstract]   [Full Text] [Related]  

  • 36. [Drug National Policy].
    Rev Saude Publica; 2000 Apr; 34(2):206-9. PubMed ID: 10881160
    [No Abstract]   [Full Text] [Related]  

  • 37. New rules for US drug reimbursement.
    Bouchie A
    Nat Biotechnol; 2003 Oct; 21(10):1119-20. PubMed ID: 14520382
    [No Abstract]   [Full Text] [Related]  

  • 38. TRIPS, pharmaceuticals, developing countries, and the Doha "solution".
    Sykes AO
    Chic J Int Law; 2002; 3(1):47-68. PubMed ID: 15709299
    [No Abstract]   [Full Text] [Related]  

  • 39. [Critical analysis of drug policy in Brazil].
    Zepeda Bermúdez JA; de Albuquerque Possas C
    Bol Oficina Sanit Panam; 1995 Sep; 119(3):270-7. PubMed ID: 7576188
    [No Abstract]   [Full Text] [Related]  

  • 40. [The world population does not have the drugs it needs. WHO report recommends more stringent control of the drug industry].
    Asplund K
    Lakartidningen; 2005 Feb 14-20; 102(7):450-1. PubMed ID: 15768693
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.